Maintaining adequate and consistent accrual of patients is important for small clinical trials and crucial to large multicentre, multinational clinical trials, in which participants often number in the thousands. Trial recruitment that is slower than expected can result in prolonged trial durations, increased costs, uneven workload, and morale problems, both for trial participants and trialists.1 Furthermore, when recruitment is so poor that it needs to be curtailed before the trial's target sample size is reached, study power is reduced and there may be a need to revise study endpoints.2
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Hunninghake DB, Darby CA, Probstfield JL. Recruitment experience in clinical trials: literature summary and annotated bibliography. Control Clin Trials 1987; 8 (4 Suppl): 6S-30S.
- 2. Keech AC, Gebski VJ. Managing the resource demands of a large sample size in clinical trials: can you succeed with fewer subjects? Med J Aust 2002; 177: 445-447. <eMJA full text>
- 3. Moher D, Schulz K, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomised trials. Lancet 2001; 357: 1191-1194.
- 4. The coronary drug project: design, methods and baseline results. Circulation 1973; 47 (3 Suppl): I1-50.
- 5. Newcomb PA, Love RR, Phillips JL, Buckmaster BJ. Using population based cancer registry for recruitment in a pilot cancer control study. Prev Med 1990; 19: 61-65.
- 6. Peto V, Coulter A, Bond A. Factors affecting general practitioner's recruitment of patients into a prospective study. Fam Prac 1993; 10: 207-211.
- 7. Mattson ME, Curb JD, McArdle R. Participation in a clinical trial: the patient's point of view. Control Clin Trials 1985; 6: 156-167.
- 8. Carew BD, Boichot HD, Dolan NA, et al, for the SOLVD investigators. Recruitment strategies in the studies of left ventricular dysfunction (SOLVD): strategies for screening and enrolment in the two concurrent but separate trials. Control Clin Trials 1992; 13: 325-338.
- 9. Friedman L, Furberg C, DeMets D. Fundamentals of clinical trials. 3rd ed. New York: Springer, 1998.
- 10. West of Scotland Coronary Prevention Study Group. A coronary primary prevention study of Scottish men aged 40–64 years: trial design. J Clin Epidemiol 1992; 45: 849-860.
- 11. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349-1357.
None identified.